Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myfortic-based immunosuppression in de novo DCD kidney transplant recipients
ChiCTR-OPC-15006244Phase 4Not yet recruiting
- Sponsor
- First affiliated hospital, College of Medicine, Zhejiang university
- Start
- Jan 1990
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mycophenolate sodium in kidney transplant, sponsored by First affiliated hospital, College of Medicine, Zhejiang university. Primary endpoints: Incidence of acute rejection, Graft survival rate and 1 more. Planned start Jan 1990; status: not yet recruiting.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant
Beyond the preview
Go deeper on ChiCTR-OPC-15006244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006244.